Article Details

William Blair Reaffirms “Outperform” Rating for Biohaven Pharmaceutical (NYSE:BHVN)

Retrieved on: 2018-11-24 22:50:16

Tags for this article:

Click the tags to see associated articles and topics

William Blair Reaffirms “Outperform” Rating for Biohaven Pharmaceutical (NYSE:BHVN). View article details on hiswai:

Excerpt

<div><b>AQR Capital Management</b> LLC acquired a new stake in Biohaven Pharmaceutical during the 3rd quarter worth approximately $218,000. Finally ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo